D-Ribose
supporting cellular energy production
D-Ribose is a natural sugar crucial for cellular energy production (ATP) and genetic material, with supplementation explored for conditions involving energy depletion, though evidence is limited.
Quick answer
What it is: D-Ribose is a naturally occurring five-carbon sugar that is a fundamental component of adenosine triphosphate (ATP), the primary energy molecule in the body.
May support:Heart Failure, Chronic Fatigue, Chronic Fatigue Syndrome
Evidence:Evidence · Grade C
Evidence Summary
As no specific PubMed studies were provided, the evidence grade for D-Ribose in the listed ailments is considered preliminary. The rationale for its use is primarily based on its known biochemical role in ATP synthesis and theoretical considerations regarding energy metabolism. Any claims regarding efficacy would currently be speculative without direct clinical trial data.
Last reviewed · Jun 2026
Have you tried D-Ribose?
Vote in 5 seconds. Add details if you want.
Your experience for Heart Failure:
Commonly Combined With
Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.
Community signal breakdown
Where this remedy is being discussed across the web and community.
People Like Me insights
As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Community Discussions
What people say about D-Ribose
Latest News
Latest news on D-Ribose
Health Videos
Health videos on D-Ribose
Why It Works
How it works in more detail
How to use
Always consult a qualified clinician.Editorial guidance
- Antidiabetic medications (may enhance blood sugar lowering effects)
- Diabetic (use with caution and monitor blood sugar)
- Pregnant or breastfeeding (lack of sufficient safety data)
Community tips
No community tips yet — be the first to share what worked for you.
Suggested dosage
General guidance — discuss specifics with a clinician.
Active medicinal compounds
Traditional use
Safety
Safety warnings
Avoid if
- Diabetic (use with caution and monitor blood sugar)
- Pregnant or breastfeeding (lack of sufficient safety data)
Medication interactions
- Antidiabetic medications (may enhance blood sugar lowering effects)
Reported side effects
- Mild gastrointestinal upset
- Diarrhea (at high doses)
- Hypoglycemia (in susceptible individuals or with high doses)
- Headache
General guidance — discuss specifics with a clinician.
Evidence ecosystem
Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.
Overall grade (C)
As no specific PubMed studies were provided, the evidence grade for D-Ribose in the listed ailments is considered preliminary. The rationale for its use is primarily based on its known biochemical role in ATP synthesis and theoretical considerations regarding energy metabolism. Any claims regarding efficacy would currently be speculative without direct clinical trial data.
Clinical Trial Registries(1)
Registered ongoing or completed trials (ClinicalTrials.gov).
n=200 · NCT07495943 · NOT_YET_RECRUITING · NOT_YET_RECRUITING
This multicenter, randomized, double-blind, placebo-controlled study will evaluate whether an oral supplement containing 2-Aticyto Complex and D-ribose (FibroThol), added to ongoing standard medical treatment, improves pain, symptoms, and clinical course in adults with fibromyalgia syndrome. Eligible participants are adults aged 18 to 65 years who have had fibromyalgia for at least 1 year and have been receiving pregabalin and/or duloxetine for at least 3 months. Participants will be randomly assigned to receive either FibroThol or placebo, administered as 15 mL three times daily for 4 weeks, while continuing their existing treatment. Follow-up assessments will be performed at baseline, week 2, and week 4 using patient-reported symptom and function measures. The study aims to determine whether this supportive supplement provides additional benefit compared with placebo in patients with persistent symptoms despite standard therapy.
Clinical TrialClinicalTrials.govModerate Quality
Limitations: A significant limitation is the absence of specific PubMed studies for review, meaning there is no direct scientific evidence from clinical trials to support efficacy for the listed ailments. Without such studies, it is impossible to assess study design, sample size, methodology, or outcomes, which are critical for determining the strength and reliability of any potential benefits. Therefore, any potential benefits remain unproven in a clinical context.
This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.
Tried D-Ribose?
Help others see what actually works.
Tried D-Ribose?
Real-world results help others choose what's worth trying.